FcyRs in health and disease

Current Topics in Microbiology and Immunology

Volumn 350, Issue , 2010, Pages 105-125

  Nimmerjahn, Falk ^a   Ravetch, Jeffrey V ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD16 ANTIGEN; CD209 ANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN HEAVY CHAIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MANNAN BINDING LECTIN; NEUTRALIZING ANTIBODY; SERUM AMYLOID P; LIGAND;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY DEPENDENT ENHANCEMENT; ANTIBODY RESPONSE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; GLYCOSYLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPER IGM SYNDROME; IMMUNE EVASION; IMMUNOGLOBULIN DEFICIENCY; INFECTION SENSITIVITY; INFLAMMATION; INNATE IMMUNITY; LIGAND BINDING; MACROPHAGE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THROMBOCYTOPENIA; ANIMAL; CHEMISTRY; CLASSIFICATION; GENE EXPRESSION REGULATION; IMMUNITY; IMMUNOLOGY; INFECTION; METABOLISM; MICROBIOLOGY; MOUSE; REVIEW; VIROLOGY;

ANIMALS; AUTOIMMUNE DISEASES; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY; IMMUNOGLOBULIN G; INFECTION; LIGANDS; MICE; RECEPTORS, IGG;

EID: 79960906994     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2010-86     Document Type: Article

References (138)

1. Agrawal A, Singh PP, Bottazzi B, Garlanda C, Mantovani A (2009) Pattern recognition by pentraxins. Adv Exp Med Biol 653:98-116
2. Albert H, Collin M, Dudziak D, Ravetch JV, Nimmerjahn F (2008) In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner. Proc Natl Acad Sci USA 105:15005-15009
3. Allhorn M, Collin M (2009) Sugar-free antibodies-the bacterial solution to autoimmunity? Ann NY Acad Sci 1173:664-669
4. Allhorn M, Olin AI, Nimmerjahn F, Collin M (2008) Human IgG/Fc gamma R interactions are modulated by streptococcal IgG glycan hydrolysis. PLoS One 3:e1413
5. Anderson CL, Grey HM (1974) Receptors for aggregated IgG on mouse lymphocytes: Their presence on thymocytes, thymus-derived, and bone marrow-derived lymphocytes. J Exp Med 139:1175-1188
6. Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV (2008a) Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 320:373-376 (Pubitemid 351555659)
7. Anthony RM, Wermeling F, Karlsson MC, Ravetch JV (2008b) Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc Natl Acad Sci USA 105:19571-19578
8. Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA (2007) The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 25:21-50 (Pubitemid 46697901)
9. Atalay R, Zimmermann A, Wagner M, Borst E, Benz C, Messerle M, Hengel H (2002) Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol 76:8596-8608 (Pubitemid 34864054)
10. Azeredo da Silveira S, Kikuchi S, Fossati-Jimack L, Moll T, Saito T, Verbeek JS, Botto M, Walport MJ, Carroll M, Izui S (2002) Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody. J Exp Med 195:665-672 (Pubitemid 34259712)
11. Baerenwaldt A, Nimmerjahn F (2008) Immune regulation - Fc gamma RIIB - regulating the balance between protective and autoreactive immune responses. Immun Cell Biol 86:482-484
12. Ballow M (2002) Primary immunodeficiency disorders: Antibody deficiency. J Allergy Clin Immunol 109:581-591 (Pubitemid 34327181)
13. Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, Mehlhop E, Johnson S, Diamond MS, Beatty PR, Harris E (2010) Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog 6:e1000790
14. Baudino L, Nimmerjahn F, Azeredo da Silveira S, Martinez-Soria E, Saito T, Carroll M, Ravetch JV, Verbeek JS, Izui S (2008) Differential contribution of three activating IgG Fc receptors (FcgammaRI, FcgammaRIII, and FcgammaRIV) to IgG2a- and IgG2b-induced autoimmune hemolytic anemia in mice. J Immunol 180:1948-1953
15. Bergamaschi A, David A, Le Rouzic E, Nisole S, Barre-Sinoussi F, Pancino G (2009) The CDK inhibitor p21Cip1/WAF1 is induced by FcgammaR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages. J Virol 83:12253-12265
16. Bevaart L, Jansen MJ, van Vugt MJ, Verbeek JS, van de Winkel JG, Leusen JH (2006) The highaffinity IgG receptor, FcgammaRI, plays a central role in antibody therapy of experimental melanoma. Cancer Res 66:1261-1264 (Pubitemid 43259901)
17. Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW (1999) The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J Exp Med 190:585-590 (Pubitemid 29395386)
18. Bharadwaj D, Mold C, Markham E, Du Clos TW (2001) Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis. J Immunol 166:6735-6741 (Pubitemid 32467217)
19. Bolland S, Ravetch JV (1999) Inhibitory pathways triggered by ITIM-containing receptors. Adv Immunol 72:149-177 (Pubitemid 30224825)
20. Bolland S, Ravetch JV (2000) Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13:277-285
21. Bond A, Cooke A, Hay FC (1990) Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis. Eur J Immunol 20:2229-2233 (Pubitemid 20368207)
22. Boruchov AM, Heller G, Veri MC, Bonvini E, Ravetch JV, Young JW (2005) Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest 115:2914-2923 (Pubitemid 41434419)
23. Bredius RG, Derkx BH, Fijen CA, de Wit TP, de Haas M, Weening RS, van de Winkel JG, Out TA (1994) Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 170:848-853
24. Briles DE, Forman C, Hudak S, Claflin JL (1984a) The effects of idiotype on the ability of IgG1 anti-phosphorylcholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae. Eur J Immunol 14:1027-1030 (Pubitemid 15212224)
25. Briles DE, Forman C, Hudak S, Claflin JL (1984b) The effects of subclass on the ability of antiphosphocholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae. J Mol Cell Immunol 1:305-309 (Pubitemid 15125094)
26. Brouwer KC, Lal RB, Mirel LB, Yang C, van Eijk AM, Ayisi J, Otieno J, Nahlen BL, Steketee R, Lal AA, Shi YP (2004) Polymorphism of Fc receptor IIa for IgG in infants is associated with susceptibility to perinatal HIV-1 infection. AIDS 18:1187-1194 (Pubitemid 38738518)
27. Bruhns P, Samuelsson A, Pollard JW, Ravetch JV (2003) Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity 18:573-581 (Pubitemid 36513638)
28. Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S, Daeron M (2009) Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 113:3716-3725
29. Carroll MC (2004) The complement system in regulation of adaptive immunity. Nat Immunol 5:981-986 (Pubitemid 41057714)
30. Cartron G, Dacheux L, Salles G, Solal-Celigny P, Bardos P, Colombat P, Watier H (2002) Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood 99:754-758 (Pubitemid 34525533)
31. Clatworthy MR, Smith KG (2004) FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J Exp Med 199:717-723 (Pubitemid 38316438)
32. Clatworthy MR, Willcocks L, Urban B, Langhorne J, Williams TN, Peshu N, Watkins NA, Floto RA, Smith KG (2007) Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. Proc Natl Acad Sci USA 104:7169-7174 (Pubitemid 47186027)
33. Clynes R, Ravetch JV (1995) Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity 3:21-26
34. Collin M, Olsen A (2001) Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect Immun 69:7187-7189 (Pubitemid 32995485)
35. Daeron M, Lesourne R (2006) Negative signaling in Fc receptor complexes. Adv Immunol 89: 39-86
36. David A, Saez-Cirion A, Versmisse P, Malbec O, Iannascoli B, Herschke F, Lucas M, Barre- Sinoussi F, Mouscadet JF, Daeron M, Pancino G (2006) The engagement of activating FcgammaRs inhibits primate lentivirus replication in human macrophages. J Immunol 177:6291-6300 (Pubitemid 44628847)
37. Dhodapkar KM, Kaufman JL, Ehlers M, Banerjee DK, Bonvini E, Koenig S, Steinman RM, Ravetch JV, Dhodapkar MV (2005) Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody- coated tumor cells. Proc Natl Acad Sci USA 102:2910-2915 (Pubitemid 40299890)
38. Dubin G, Socolof E, Frank I, Friedman HM (1991) Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J Virol 65:7046-7050
39. Dutertre CA, Bonnin-Gelize E, Pulford K, Bourel D, Fridman WH, Teillaud JL (2008) A novel subset of NK cells expressing high levels of inhibitory FcgammaRIIB modulating antibodydependent function. J Leukoc Biol 84:1511-1520 (Pubitemid 352774486)
40. Ferrara C, Stuart F, Sondermann P, Brunker P, Umana P (2006) The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. J Biol Chem 281:5032-5036 (Pubitemid 43847767)
41. Fijen CA, Bredius RG, Kuijper EJ, Out TA, De Haas M, De Wit AP, Daha MR, De Winkel JG (2000) The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals. Clin Exp Immunol 120:338-345 (Pubitemid 30304231)
42. Florese RH, Van Rompay KK, Aldrich K, Forthal DN, Landucci G, Mahalanabis M, Haigwood N, Venzon D, Kalyanaraman VS, Marthas ML, Robert-Guroff M (2006) Evaluation of passively transferred, nonneutralizing antibody-dependent cellular cytotoxicity-mediating IgG in protection of neonatal rhesus macaques against oral SIVmac251 challenge. J Immunol 177:4028-4036 (Pubitemid 44359936)
43. Forthal DN, Moog C (2009) Fc receptor-mediated antiviral antibodies. Curr Opin HIV AIDS 4:388-393
44. Fossati-Jimack L, Ioan-Facsinay A, Reininger L, Chicheportiche Y, Watanabe N, Saito T, Hofhuis FM, Gessner JE, Schiller C, Schmidt RE, Honjo T, Verbeek JS, Izui S (2000) Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III. J Exp Med 191:1293-1302 (Pubitemid 30227118)
45. Frank I, Friedman HM (1989) A novel function of the herpes simplex virus type 1 Fc receptor: Participation in bipolar bridging of antiviral immunoglobulin G. J Virol 63:4479-4488 (Pubitemid 19257820)
46. Gavin AL, Tan PS, Hogarth PM (1998) Gain-of-function mutations in FcgammaRI of NOD mice: Implications for the evolution of the Ig superfamily. EMBO J 17:3850-3857 (Pubitemid 28333971)
47. Giorgini A, Brown HJ, Lock HR, Nimmerjahn F, Ravetch JV, Verbeek JS, Sacks SH, Robson MG (2008) Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies. J Immunol 181:8745-8752
48. Gjertsson I, Kleinau S, Tarkowski A (2002) The impact of Fcgamma receptors on Staphylococcus aureus infection. Microb Pathog 33:145-152 (Pubitemid 35193460)
49. Gomez-Roman VR, Patterson LJ, Venzon D, Liewehr D, Aldrich K, Florese R, Robert-Guroff M (2005) Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251. J Immunol 174:2185-2189 (Pubitemid 40223963)
50. Gray CA, Lawrence RA (2002) A role for antibody and Fc receptor in the clearance of Brugia malayi microfilariae. Eur J Immunol 32:1114-1120 (Pubitemid 34428828)
51. Hamaguchi Y, Xiu Y, Komura K, Nimmerjahn F, Tedder TF (2006) Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy. J Exp Med 203:743-753, Epub 2006 Mar 6
52. Hazenbos WL, Gessner JE, Hofhuis FM, Kuipers H, Meyer D, Heijnen IA, Schmidt RE, Sandor M, Capel PJ, Daeron M, van de Winkel JG, Verbeek JS (1996) Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. Immunity 5:181-188 (Pubitemid 26301094)
53. Hellwig SM, van Oirschot HF, Hazenbos WL, van Spriel AB, Mooi FR, van De Winkel JG (2001) Targeting to Fcgamma receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis. J Infect Dis 183:871-879 (Pubitemid 32207055)
54. Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, Lanigan CM, Landucci G, Forthal DN, Parren PW, Marx PA, Burton DR (2007) Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449:101-104 (Pubitemid 47373775)
55. Hirano M, Davis RS, Fine WD, Nakamura S, Shimizu K, Yagi H, Kato K, Stephan RP, Cooper MD (2007) IgEb immune complexes activate macrophages through FcgammaRIV binding. Nat Immunol 8:762-771 (Pubitemid 46965352)
56. Hogarth PM (2002) Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr Opin Immunol 14:798-802 (Pubitemid 35292429)
57. Holl V, Hemmerter S, Burrer R, Schmidt S, Bohbot A, Aubertin AM, Moog C (2004) Involvement of Fc gamma RI (CD64) in the mechanism of HIV-1 inhibition by polyclonal IgG purified from infected patients in cultured monocyte-derived macrophages. J Immunol 173:6274-6283 (Pubitemid 39487786)
58. Holl V, Peressin M, Decoville T, Schmidt S, Zolla-Pazner S, Aubertin AM, Moog C (2006a) Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells. J Virol 80:6177-6181 (Pubitemid 43849196)
59. Holl V, Peressin M, Schmidt S, Decoville T, Zolla-Pazner S, Aubertin AM, Moog C (2006b) Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation. Blood 107:4466-4474 (Pubitemid 43801374)
60. Huber VC, Lynch JM, Bucher DJ, Le J, Metzger DW (2001) Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections. J Immunol 166:7381-7388 (Pubitemid 32525614)
61. Ioan-Facsinay A, de Kimpe SJ, Hellwig SM, van Lent PL, Hofhuis FM, van Ojik HH, Sedlik C, da Silveira SA, Gerber J, de Jong YF, Roozendaal R, Aarden LA, van den Berg WB, Saito T, Mosser D, Amigorena S, Izui S, van Ommen GJ, van Vugt M, van de Winkel JG, Verbeek JS (2002) FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 16:391-402 (Pubitemid 34260917)
62. Iwasaki A, Medzhitov R (2010) Regulation of adaptive immunity by the innate immune system. Science 327:291-295
63. Jefferis R (2009) Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov 8:226-234
64. Johansson BP, Shannon O, Bjorck L (2008) IdeS: A bacterial proteolytic enzyme with therapeutic potential. PLoS One 3:e1692
65. Kalergis AM, Ravetch JV (2002) Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J Exp Med 195:1653-1659 (Pubitemid 34666079)
66. Kaminski MS, Kitamura K, Maloney DG, Campbell MJ, Levy R (1986) Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants. J Immunol 136:1123-1130 (Pubitemid 16146408)
67. Kaneko Y, Nimmerjahn F, Madaio MP, Ravetch JV (2006a) Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med 203:789-797, Epub 2006 Mar 6
68. Kaneko Y, Nimmerjahn F, Ravetch JV (2006b) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313:670-673 (Pubitemid 44201145)
69. Karlsson Hedestam GB, Fouchier RA, Phogat S, Burton DR, Sodroski J, Wyatt RT (2008) The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat Rev Microbiol 6:143-155
70. Kima PE, Constant SL, Hannum L, Colmenares M, Lee KS, Haberman AM, Shlomchik MJ, McMahon-Pratt D (2000) Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J Exp Med 191:1063-1068
71. Kipps TJ, Parham P, Punt J, Herzenberg LA (1985) Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J Exp Med 161:1-17 (Pubitemid 15169717)
72. Lambert SL, Okada CY, Levy R (2004) TCR vaccines against a murine T cell lymphoma: A primary role for antibodies of the IgG2c class in tumor protection. J Immunol 172:929-936 (Pubitemid 38113751)
73. Langone JJ (1982) Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci. Adv Immunol 32:157-252
74. Leclerc JC, Plater C, Fridman WH (1977) The role of the Fc receptor (FcR) of thymus-derived lymphocytes. I. Presence of FcR on cytotoxic lymphocytes and absence of direct role in cytotoxicity. Eur J Immunol 7:543-548 (Pubitemid 8172831)
75. Littaua R, Kurane I, Ennis FA (1990) Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol 144:3183-3186 (Pubitemid 20149498)
76. Loke H, Bethell D, Phuong CX, Day N, White N, Farrar J, Hill A (2002) Susceptibility to dengue hemorrhagic fever in vietnam: Evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes. Am J Trop Med Hyg 67:102-106 (Pubitemid 35034327)
77. Lu J, Marnell LL, Marjon KD, Mold C, Du Clos TW, Sun PD (2008) Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature 456:989-992
78. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB (1995) Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannosebinding protein. Nat Med 1:237-243
79. Mancardi DA, Iannascoli B, Hoos S, England P, Daeron M, Bruhns P (2008) FcgammaRIV is a mouse IgE receptor that resembles macrophage FcepsilonRI in humans and promotes IgEinduced lung inflammation. J Clin Invest 118:3738-3750
80. Marjon KD, Marnell LL, Mold C, Du Clos TW (2009) Macrophages activated by C-reactive protein through Fc gamma RI transfer suppression of immune thrombocytopenia. J Immunol 182:1397-1403
81. Markine-Goriaynoff D, Coutelier JP (2002) Increased efficacy of the immunoglobulin G2a subclass in antibody-mediated protection against lactate dehydrogenase-elevating virusinduced polioencephalomyelitis revealed with switch mutants. J Virol 76:432-435 (Pubitemid 33139030)
82. Marnell L, Mold C, Du Clos TW (2005) C-reactive protein: Ligands, receptors and role in inflammation. Clin Immunol 117:104-111 (Pubitemid 41407719)
83. Meyer D, Schiller C, Westermann J, Izui S, Hazenbos WL, Verbeek JS, Schmidt RE, Gessner JE (1998) FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia. Blood 92:3997-4002 (Pubitemid 28544311)
84. Mimura Y, Sondermann P, Ghirlando R, Lund J, Young SP, Goodall M, Jefferis R (2001) Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding. J Biol Chem 276:45539-45547
85. Mizuochi T, Hamako J, Nose M, Titani K (1990) Structural changes in the oligosaccharide chains of IgG in autoimmune MRL/Mp-lpr/lpr mice. J Immunol 145:1794-1798 (Pubitemid 20336746)
86. Nandakumar KS, Holmdahl R (2008) Therapeutic cleavage of IgG: New avenues for treating inflammation. Trends Immunol 29:173-178
87. Nandakumar KS, Collin M, Olsen A, Nimmerjahn F, Blom AM, Ravetch JV, Holmdahl R (2007a) Endoglycosidase treatment abrogates IgG arthritogenicity: Importance of IgG glycosylation in arthritis. Eur J Immunol 37:2973-2982 (Pubitemid 47578315)
88. Nandakumar KS, Johansson BP, Bjorck L, Holmdahl R (2007b) Blocking of experimental arthritis by cleavage of IgG antibodies in vivo. Arthritis Rheum 56:3253-3260 (Pubitemid 47585420)
89. Nimmerjahn F, Ravetch JV (2005) Divergent immunoglobulin G subclass activity through selective Fc receptor binding. Science 310:1510-1512 (Pubitemid 41746349)
90. Nimmerjahn F, Ravetch JV (2006) Fcgamma receptors: Old friends and new family members. Immunity 24:19-28 (Pubitemid 43077197)
91. Nimmerjahn F, Ravetch JV (2007a) Antibodies, Fc receptors and cancer. Curr Opin Immunol 19:239-245 (Pubitemid 46356962)
92. Nimmerjahn F, Ravetch JV (2007b) The antiinflammatory activity of IgG: The intravenous IgG paradox. J Exp Med 204:11-15 (Pubitemid 46148750)
93. Nimmerjahn F, Ravetch JV (2008a) Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol 26:513-533 (Pubitemid 351600384)
94. Nimmerjahn F, Ravetch JV (2008b) Fc gamma receptors as regulators of immune responses. Nat Rev Immunol 8:34-47
95. Nimmerjahn F, Bruhns P, Horiuchi K, Ravetch JV (2005) FcgammaRIV: A novel FcR with distinct IgG subclass specificity. Immunity 23:41-51 (Pubitemid 41019656)
96. Nimmerjahn F, Anthony RM, Ravetch JV (2007) Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc Natl Acad Sci USA 104:8433-8437 (Pubitemid 47175505)
97. Otten MA, van der Bij GJ, Verbeek SJ, Nimmerjahn F, Ravetch JV, Beelen RH, van de Winkel JG, van Egmond M (2008) Experimental antibody therapy of liver metastases reveals functional redundancy between Fc gammaRI and Fc gammaRIV. J Immunol 181:6829-6836
98. Padigel UM, Farrell JP (2005) Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells. J Immunol 174:6340-6345 (Pubitemid 40663827)
99. Pathan N, Faust SN, Levin M (2003) Pathophysiology of meningococcal meningitis and septicaemia. Arch Dis Child 88:601-607 (Pubitemid 36783042)
100. Perez-Bercoff D, David A, Sudry H, Barre-Sinoussi F, Pancino G (2003) Fcgamma receptormediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages. J Virol 77:4081-4094 (Pubitemid 36350948)
101. Radaev S, Motyka S, Fridman WH, Sautes-Fridman C, Sun PD (2001) The structure of a human type III Fcgamma receptor in complex with Fc. J Biol Chem 276:16469-16477
102. Ravetch JV, Clynes RA (1998) Divergent roles for Fc receptors and complement in vivo. Annu Rev Immunol 16:421-432 (Pubitemid 28183371)
103. Ravetch JV, Lanier LL (2000) Immune inhibitory receptors. Science 290:84-89
104. Ravetch JV, Nimmerjahn F (2008) Fc receptors. In: Paul WE (ed) Fundamental immunology, 5th edn. Lippincott-Raven, Philadelphia, pp 684-705
105. Rodriguez ME, van der Pol WL, Sanders LA, van de Winkel JG (1999) Crucial role of FcgammaRIIa (CD32) in assessment of functional anti-Streptococcus pneumoniae antibody activity in human sera. J Infect Dis 179:423-433 (Pubitemid 29086645)
106. Rodriguez ME, Hellwig SM, Hozbor DF, Leusen J, van der Pol WL, van de Winkel JG (2001) Fc receptor-mediated immunity against Bordetella pertussis. J Immunol 167:6545-6551 (Pubitemid 33081590)
107. Rodriguez W, Mold C, Kataranovski M, Hutt JA, Marnell LL, Verbeek JS, Du Clos TW (2007) C-reactive protein-mediated suppression of nephrotoxic nephritis: Role of macrophages, complement, and Fcgamma receptors. J Immunol 178:530-538 (Pubitemid 46033637)
108. Rook GA, Steele J, Brealey R, Whyte A, Isenberg D, Sumar N, Nelson JL, Bodman KB, Young A, Roitt IM et al (1991) Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J Autoimmun 4:779-794
109. Samuelsson A, Towers TL, Ravetch JV (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291:484-486 (Pubitemid 32097072)
110. Scallon BJ, Tam SH, McCarthy SG, Cai AN, Raju TS (2007) Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol Immunol 44:1524-1534 (Pubitemid 44792756)
111. Schlageter AM, Kozel TR (1990) Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide. Infect Immun 58:1914-1918 (Pubitemid 20176391)
112. Schmidt RE, Gessner JE (2005) Fc receptors and their interaction with complement in autoimmunity. Immunol Lett 100:56-67 (Pubitemid 41262034)
113. Shields RL, Namenuk AK, Hong K, Meng YG, Rae J, Briggs J, Xie D, Lai J, Stadlen A, Li B, Fox JA, Presta LG (2001) High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. J Biol Chem 276:6591-6604
114. Shields RL, Lai J, Keck R, O'Connell LY, Hong K, Meng YG, Weikert SH, Presta LG (2002) Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem 277:26733-26740, Epub 2002 May 1 (Pubitemid 34951677)
115. Shinkawa T, Nakamura K, Yamane N, Shoji-Hosaka E, Kanda Y, Sakurada M, Uchida K, Anazawa H, Satoh M, Yamasaki M, Hanai N, Shitara K (2003) The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 278:3466-3473, Epub 2002 Nov 8 (Pubitemid 36801263)
116. Smith I, Vedeler C, Halstensen A (2003) FcgammaRIIa and FcgammaRIIIb polymorphisms were not associated with meningococcal disease in Western Norway. Epidemiol Infect 130:193-199 (Pubitemid 36511957)
117. Sondermann P, Huber R, Oosthuizen V, Jacob U (2000) The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature 406:267-273 (Pubitemid 30604397)
118. Sprague ER, Reinhard H, Cheung EJ, Farley AH, Trujillo RD, Hengel H, Bjorkman PJ (2008) The human cytomegalovirus Fc receptor gp68 binds the Fc CH2-CH3 interface of immunoglobulin G. J Virol 82:3490-3499 (Pubitemid 351429924)
119. Stout RD, Herzenberg LA (1975) The Fc receptor on thymus-derived lymphocytes. I. Detection of a subpopulation of murine T lymphocytes bearing the Fc receptor. J Exp Med 142:611-621
120. Syed SN, Konrad S, Wiege K, Nieswandt B, Nimmerjahn F, Schmidt RE, Gessner JE (2009) Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a. Eur J Immunol 39:3343-3356
121. Sylvestre D, Clynes R, Ma M, Warren H, Carroll MC, Ravetch JV (1996) Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J Exp Med 184:2385-2392 (Pubitemid 27023737)
122. Tackenberg B, Jelcic I, Baerenwaldt A, Oertel WH, Sommer N, Nimmerjahn F, Lunemann JD (2009) Impaired inhibitory Fc gamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy. Proc Natl Acad Sci USA 106:4788-4792
123. Takai T (2002) Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2:580-592 (Pubitemid 37328733)
124. Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV (1996) Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 379:346-349 (Pubitemid 26033077)
125. Takeda A, Tuazon CU, Ennis FA (1988) Antibody-enhanced infection by HIV-1 via Fc receptormediated entry. Science 242:580-583 (Pubitemid 18263201)
126. Thomas-Rudolph D, Du Clos TW, Snapper CM, Mold C (2007) C-reactive protein enhances immunity to Streptococcus pneumoniae by targeting uptake to Fc gamma R on dendritic cells. J Immunol 178:7283-7291 (Pubitemid 46847455)
127. Uchida J, Hamaguchi Y, Oliver JA, Ravetch JV, Poe JC, Haas KM, Tedder TF (2004) The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J Exp Med 199:1659-1669 (Pubitemid 38821999)
128. van de Geijn FE, Wuhrer M, Selman MH, Willemsen SP, de Man YA, Deelder AM, Hazes JM, Dolhain RJ (2009) Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: Results from a large prospective cohort study. Arthritis Res Ther 11:R193
129. Verma A, Ngundi MM, Meade BD, De Pascalis R, Elkins KL, Burns DL (2009) Analysis of the Fc gamma receptor-dependent component of neutralization measured by anthrax toxin neutralization assays. Clin Vaccine Immunol 16:1405-1412
130. Walker BD, Burton DR (2008) Toward an AIDS vaccine. Science 320:760-764 (Pubitemid 351929619)
131. Weng WK, Levy R (2003) Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. J Clin Oncol 21:3940-3947, Epub 2003 Sep 15 (Pubitemid 46606207)
132. Weng WK, Czerwinski D, Timmerman J, Hsu FJ, Levy R (2004) Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype. J Clin Oncol 22:4717-4724, Epub 2004 Oct 13
133. Willcocks LC, Smith KG, Clatworthy MR (2009) Low-affinity Fcgamma receptors, autoimmunity and infection. Expert Rev Mol Med 11:e24
134. Wood P (2009) Primary antibody deficiency syndromes. Ann Clin Biochem 46:99-108
135. Woof JM, Burton DR (2004) Human antibody-Fc receptor interactions illuminated by crystal structures. Nat Rev Immunol 4:89-99 (Pubitemid 38209203)
136. Yee AM, Phan HM, Zuniga R, Salmon JE, Musher DM (2000) Association between FcgammaRIIa- R131 allotype and bacteremic pneumococcal pneumonia. Clin Infect Dis 30:25-28 (Pubitemid 30067057)
137. Yoneto T, Waki S, Takai T, Tagawa Y, Iwakura Y, Mizuguchi J, Nariuchi H, Yoshimoto T (2001) A critical role of Fc receptor-mediated antibody-dependent phagocytosis in the host resistance to blood-stage Plasmodium berghei XAT infection. J Immunol 166:6236-6241 (Pubitemid 32440755)
138. Yuan FF, Wong M, Pererva N, Keating J, Davis AR, Bryant JA, Sullivan JS (2003) FcgammaRIIA polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol 81:192-195 (Pubitemid 36649265)